Treatment for Long COVID Cardiac Issues
For patients with Long COVID experiencing cardiac issues, treatment should focus on the specific cardiac manifestation, with corticosteroids recommended for those with myocarditis and COVID-19 pneumonia requiring supplemental oxygen, and standard heart failure therapies for those with cardiac dysfunction. 1
Diagnostic Approach
Initial evaluation of patients with suspected cardiac involvement in Long COVID should include:
Basic cardiac testing 1:
- ECG
- High-sensitivity cardiac troponin (cTn)
- Echocardiogram
- Ambulatory rhythm monitoring
- Chest imaging (X-ray and/or CT)
- Pulmonary function tests when appropriate
Advanced imaging for specific indications:
Treatment Algorithm Based on Cardiac Manifestation
1. Myocarditis
- Mild to moderate myocarditis: Hospitalization recommended, ideally at an advanced heart failure center 1
- Fulminant myocarditis: Management at centers with expertise in advanced heart failure, mechanical circulatory support, and other advanced therapies 1
- With COVID-19 pneumonia requiring oxygen: Corticosteroids 1
- With pericardial involvement: NSAIDs, colchicine, and/or prednisone for chest pain and inflammation 1
- With hemodynamic compromise or MIS-A: Consider intravenous corticosteroids 1
- Follow-up: Surveillance testing (ECG, echocardiogram, ambulatory rhythm monitor, CMR) 3-6 months after presentation 1
2. Heart Failure
- Initiate guideline-directed medical therapy for heart failure before discharge and titrate as appropriate in the outpatient setting 1
- For mildly reduced LV function with stable hemodynamics: Consider low-dose aldosterone system inhibitors 1
- For patients with supraventricular arrhythmias who are hemodynamically stable: Consider beta-blockers 1
3. Pericarditis
- NSAIDs as first-line treatment 1
- Add low-dose colchicine or prednisone for persistent chest pain 1
- Taper dose based on symptoms and clinical findings 1
4. Post-Acute Sequelae of COVID-19 with Cardiovascular Symptoms (PASC-CVS)
- For patients with tachycardia, exercise intolerance, palpitations, chest pain, and dyspnea without objective evidence of cardiovascular disease:
Special Considerations
Activity Restrictions
- Avoid strenuous physical activity for 3-6 months after myocarditis 1
- Return to play decisions should be based on:
- Absence of cardiopulmonary symptoms
- Resolution of laboratory evidence of myocardial injury
- Normalization of LV systolic function
- Absence of spontaneous/inducible cardiac arrhythmias on ECG monitoring and exercise stress testing 1
High-Risk Patients Requiring Cardiology Consultation
- Patients with abnormal cardiac test results
- Known cardiovascular disease with new or worsening symptoms
- Documented cardiac complications during SARS-CoV-2 infection
- Persistent cardiopulmonary symptoms not otherwise explained 1
Pitfalls and Caveats
Avoid unnecessary imaging: Echocardiography should not routinely be performed in all patients with COVID-19 disease 1
Risk of contamination: The risk of contamination during transesophageal echocardiography is very high—consider repeat TTE, CT scan, or CMR as alternatives 1
Beta-blockers caution: While beta-blockers may help with supraventricular arrhythmias, they can precipitate cardiogenic shock in patients with greater compromise of cardiac function 1
Distinguishing causes: Cardiac symptoms must be objectively assessed to differentiate cardiac from neural (autonomic) etiology, as many Long COVID symptoms may be related to autonomic dysfunction 2
Follow-up importance: Surveillance testing is critical to gauge recovery of cardiac function and inflammation, guide heart failure management, and assess prognosis 1